ONMD · Insider Trading

OneMedNet Corp Class A Common Stock

Every open-market purchase and sale reported by ONMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
9
most recent
Open-Market Buys
7
code P
Sales
0
code S
Reporting Insiders
4
current holders
ONMD — Recent Form 4 Transactions (latest 2026-10-13)
FiledInsiderRole TypeSharesValue
2026-10-13 Jeffrey Yu Chief Medical Officer Buy +45,126 +$250.00K
2026-10-13 Thomas Kosasa Director Buy +129,758 +$750.00K
2026-10-09 Robert Lawrence Golden Chief Financial Officer MIXED +36,500 −$55.29K
2026-10-09 Aaron Green Chief Executive Officer MIXED +58,333 −$47.76K
2026-09-14 Jeffrey Yu Chief Medical Officer Buy +142,857 +$90.00K
2026-08-07 Thomas Kosasa Director Buy +1,449,275 +$1000.00K
2026-08-07 Thomas Kosasa Director Buy +1,449,275 +$1000.00K
2026-06-24 Jeffrey Yu Chief Medical Officer Buy +158,730 +$100.00K
2026-06-24 Aaron Green Chief Executive Officer Buy +36,650 +$21.01K
ONMD — Current Insider Holders
InsiderRole Shares HeldValue
Thomas Kosasa Director 1,983,573 $9.86M
Jeffrey Yu Chief Medical Officer 1,028,037 $5.11M
Aaron Green Chief Executive Officer 247,971 $1.23M
Robert Lawrence Golden Chief Financial Officer 94,291 $468.63K
ONMD Insider Trading FAQ
Who are the insiders at ONMD?
4 officers, directors and 10%+ beneficial owners currently report holdings in ONMD via SEC Form 4.
Are ONMD insiders buying or selling?
Across the 9 most recent Form 4 filings for ONMD, 7 were open-market purchases (code P) and 0 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is ONMD insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent ONMD filing is dated 2026-10-13.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the ONMD quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.